Based in Teaneck, New Jersey, John Klein is the chairman of Cambridge Therapeutics, where he draws on his experience in the health care and pharmaceutical industries to guide the organization. Under John Klein’s direction, Cambridge Therapeutics focuses on providing innovative health care solutions, including novel drug delivery systems and physician prescription dispensing.Physicians who opt to dispense from their own offices the medications that they prescribe can obtain a revenue boost. Given that the National Center for Health Statistics estimates that a typical physician writes approximately 35 prescriptions daily, adding a $10 handling surcharge on each one could result in up to $350 or more in additional daily revenue without using any additional physician time.In addition to being more profitable for the physician’s practice and investors, physician-dispensed prescriptions offer increased convenience to patients because they can receive their medications at the point of care rather than waiting in line at the pharmacy. Prescriptions dispensed in a doctor’s office also may also help to increase adherence to medication regimens. Currently, as many as 31 percent of new prescriptions go unfilled by patients, according to the Journal of General Internal Medicine.
A pharmaceutical industry executive with extensive experience helming top companies such as Ivax and Zenith Laboratories, John Klein serves as chairman of Cambridge Therapeutics, based in Teaneck, New Jersey. In addition to his other professional and civic responsibilities, John Klein serves as a trustee of Hackensack Meridian Health Hospitals.Early in 2018, Hackensack Meridian School of Medicine at Seton Hall University began accepting applications for positions in its inaugural class set to matriculate that summer. The school, a partnership between the health care system and Seton Hall, is New Jersey’s only private medical school. It was established in response to the dearth of physicians in New Jersey and the growing contemporary focus on individual wellness and community-centered care.In addition to their organization’s work on the Seton Hall educational partnership, members of the Hackensack Meridian Health Board of Trustees have supported the establishment of a scholarship endowment fund of $100 million to aid medical students in need.
As chairman of Cambridge Therapeutics, John Klein leverages 30 years of experience in generic drug development and distribution to help increase shareholder value. Beyond his role with Cambridge Therapeutics, John Klein is a trustee of Hackensack Meridian Health Hospitals.In August 2018, four Hackensack Meridian Health hospitals earned a place on U.S. News & World Report's list of the top 10 hospitals in New Jersey. Hackensack University Medical Center was ranked as the second-best hospital in the state as well as the fifth-best in the New York Metro region. Moreover, it is ranked nationally in colon cancer surgery, hip replacement, chronic obstructive pulmonary disease, and heart failure, among other areas. Jersey Shore University Medical Center, Riverview Medical Center, and Raritan Bay Medical Center were ranked as the 4th, 8th, and 10th-best hospitals in the state, respectively. It was the first time in the top 10 for Raritan Bay, which was also recognized for its high-quality treatment and care of patients with heart failure. In compiling the statewide rankings and acknowledging areas of high performance, U.S. News considered patient experience, safety, and volume as well as quality of nursing care and risk-adjusted survival and readmission rates.
